Causaly
Accelerates scientific research discovery through artificial intelligence driven literature synthesis.
What they do
Causaly provides an artificial intelligence platform that reads, understands, and visualizes millions of biomedical documents. Pharmaceutical researchers and clinical trial teams use the platform to find biological connections, map disease pathways, and identify drug targets.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Literature search and synthesis
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2017
- Total funding
- $93M raised
Notable investors: Index Ventures, Marathon Venture Capital, Pentech, EBRD.